But how did transgenders do?
/Enhanced melanoma vaccine offers improved survival for men
A second-generation melanoma vaccine being developed at UVA Cancer Center improves long-term survival for melanoma patients compared with the first-generation vaccine, new research shows. Interestingly, the benefit of the second-generation vaccine was greater for male patients than for female patients. That finding could have important implications for other cancer vaccines, the researchers say.
“We didn’t break out the results for transgenders”, Dr. Rufus T. Firefly told FWIW, “because (a) that would be discriminatory; and (b) because of federal guidelines, we aren’t allowed to use the outdated term ‘biological’ sex, so we have no way of knowing. It’s interesting to note,however, that many of the beared ladies in our study showed the same recovery rate as most of those who we used to call men. “